It’s not common for someone to pursue a second MBA, but it does happen. A second MBA could be useful for someone seeking ...
Brings more than 25 years of experience advancing and commercializing high-impact therapies for serious diseases, including those with limited or no approved treatment options ...
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease. ACI-24 anti-Abeta active immunotherapy generally safe and well to ...
Chitkara University, through its knowledge partnership with EY, introduces a pioneering online MBA program in Data Science ...